{"database": "lobbying", "table": "lobbying_activities", "is_view": false, "human_description_en": "where filing_period = \"third_quarter\", filing_year = 2017 and issue_code = \"MED\" sorted by filing_year descending", "rows": [[2018941, "843fa214-fa1e-4f7e-80b4-65162c000f2b", "3T", "WEBMD HEALTH CORP.", 55473, "WEBMD HEALTH CORP", 2017, "third_quarter", "MED", "Explore partnership opportunities with the government to disseminate healthcare and research information to physicians and consumers. Federal health care reform efforts; Privacy, security and confidentiality issues; Direct to consumer advertising; Wellness programs and incentives for creation of such programs; Pharma issues related to both advertising and deduction of expenses associated with advertising; Personal health records.", "HOUSE OF REPRESENTATIVES,SENATE", null, 10000, 0, 1, "2017-09-28T11:35:31.400000-04:00"], [2019053, "829950ed-7a30-40aa-aef0-801ff826ee61", "Q3", "MARSHALL BRACHMAN", 6848, "BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM", 2017, "third_quarter", "MED", "support funding for medical research programs", "HOUSE OF REPRESENTATIVES,SENATE", 33000, null, 0, 0, "2017-10-01T10:45:17.847000-04:00"], [2019285, "48f02549-4ad6-461e-b5ad-9d10385aa110", "Q3", "NATURAL RESOURCE RESULTS LLC", 321555, "SHINE MEDICAL TECHNOLOGIES", 2017, "third_quarter", "MED", "Support lifting cap on NNSA program for medical isotope production under AMIPA; support funding SHINE facility under same program at NNSA in FY18 approps and FY19 budget.", "Council on Environmental Quality (CEQ),Energy, Dept of,HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Office of Management & Budget (OMB),SENATE,White House Office", 10000, null, 0, 0, "2017-10-03T05:43:49.930000-04:00"], [2019426, "92e49637-697a-4f7d-8790-a47bb7494472", "Q3", "THE FRIEDLANDER GROUP", 400535604, "OHEL CHILDRENS HOME AND FAMILY SERVICES", 2017, "third_quarter", "MED", "Block Grants", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2017-10-03T12:43:45.003000-04:00"], [2019597, "90ddca98-51a5-4825-bc66-f73876dde068", "Q3", "AMERICAN COLLEGE OF CLINICAL PHARMACY", 57258, "AMERICAN COLLEGE OF CLINICAL PHARMACY", 2017, "third_quarter", "MED", "Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE", null, 128375, 0, 0, "2017-10-04T09:57:51.917000-04:00"], [2019614, "0f758f71-cb06-49ec-b9ec-015215205ffb", "Q3", "RICHARD J. SCHOLZ, P.A. (FKA JACOBS SCHOLZ & WYLER, LLC)", 400361684, "VIJUK EQUIPMENT, INC.", 2017, "third_quarter", "MED", "Pharmaceutical labeling", "Food & Drug Administration (FDA)", 18750, null, 0, 0, "2017-10-04T10:54:09.323000-04:00"], [2019708, "9f60a571-4cf3-4a24-b54e-e665afcc7d8f", "Q3", "FEDERAL SOLUTIONS, LLC", 311371, "MISSISSIPPI STATE UNIVERSITY", 2017, "third_quarter", "MED", "Labor/HHS/Education Appropriation Bill: Provisions relating to disease research.", "Education, Dept of,HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Oceanic & Atmospheric Administration (NOAA),SENATE", 50000, null, 0, 0, "2017-10-04T14:14:24.157000-04:00"], [2019717, "a1d986da-b5ec-4cf8-8e0f-408a354b7a08", "Q3", "FEDERAL SOLUTIONS, LLC", 311371, "JACKSONVILLE STATE UNIVERSITY", 2017, "third_quarter", "MED", "Labor/HHS/Education Appropriations Bill: Provisions relating to disease research, education  and development.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2017-10-04T14:16:28.327000-04:00"], [2019785, "33d112df-3bcd-450b-b723-355be0a7d488", "Q3", "GRIZZLE COMPANY", 16987, "UNIVERSITY OF LOUISVILLE", 2017, "third_quarter", "MED", "Request letters of support for a grant application to the NIH.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2017-10-04T15:31:09.197000-04:00"], [2019907, "f3baf852-d127-49ab-902d-586a7698e821", "Q3", "O'NEILL AND ASSOCIATES", 73134, "POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN)", 2017, "third_quarter", "MED", "Medicare advantage and health care reform", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2017-10-05T11:30:36.710000-04:00"], [2020158, "a99b6d22-13ad-405c-bcde-fc568d9c406a", "Q3", "RAY C CULVER III", 11468, "ARKANSAS CHILDREN'S HOSPITAL", 2017, "third_quarter", "MED", "Funding for the USDA Agricultural Research Service human nutrition research centers in the FY18 Agricultural Appropriations bill and CR (currently HR 3354 and PL 115-56).", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2017-10-05T22:14:23.870000-04:00"], [2020271, "622a9b39-025a-49af-9a7e-ab75e5a7a7ba", "Q3", "ALZHEIMER'S FOUNDATION OF AMERICA", 323158, "ALZHEIMER'S FOUNDATION OF AMERICA", 2017, "third_quarter", "MED", "S. 445 -  the Home Health Care Planning Improvement Act of 2017\nS. 464 - Independence at Home Act of 2017\nH.R. 1825, Home Health Care Planning Act\nSenate Finance CHRONIC Act", "Administration on Aging,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office", null, 30000, 0, 0, "2017-10-06T10:28:32.623000-04:00"], [2020283, "bc92c36d-0bb7-405e-993b-f0fe36524bdc", "Q3", "AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY", 3344, "AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY", 2017, "third_quarter", "MED", "biomedical research", "HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE", 50000, null, 0, 0, "2017-10-06T10:34:42.620000-04:00"], [2020304, "e7014bd4-4df9-4b4b-95b2-0096f3b54ca4", "Q3", "PARRY, ROMANI, DECONCINI & SYMMS", 30792, "AIDS HEALTHCARE FOUNDATION", 2017, "third_quarter", "MED", "Department of Labor, Health, Human Services, and Education, and Related Agencies Appropriations Act, FY 2018 - Support funding for medical treatments for HIV positive patients.  Support appropriate funding for the ADAP program.", "HOUSE OF REPRESENTATIVES,SENATE", 36000, null, 0, 0, "2017-10-06T11:01:08.300000-04:00"], [2020541, "62e11b31-a7c5-4e29-b0e6-2cc910bf6f77", "Q3", "TCH GROUP, LLC", 51478, "INTERNATIONAL AIDS VACCINE INITIATIVE", 2017, "third_quarter", "MED", "FY 18 Omnibus Appropriations bill (HR 3354), FY 18 CR (HR 601), FY 18 House and Senate State Foreign Operations Subcommittee Appropriations bills (HR 3362 and S 1780).  Specifically, continued Federal funding under USAID for AIDS vaccine research and development", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2017-10-07T12:31:05.957000-04:00"], [2020925, "74e70921-0b55-4f83-8721-7cad75d3ff48", "Q3", "HOLLAND & KNIGHT LLP", 18466, "THE BIOSIMILARS FORUM", 2017, "third_quarter", "MED", "Medicare reimbursement issues, FDA regulation of biosimilars;  S. 934, H.R. 2430, the FDA Reauthorization Act of 2017.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 120000, null, 0, 0, "2017-10-09T15:40:15.367000-04:00"], [2021128, "740bd325-7222-4eb6-ba79-344757a9eba9", "Q3", "LNE GROUP", 308811, "HOSPICE OF THE WESTERN RESERVE", 2017, "third_quarter", "MED", "Lobbied on issues related to medical/disease research.", "HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)", 30000, null, 0, 0, "2017-10-10T11:00:40.497000-04:00"], [2021190, "0035e7a7-6285-4c71-915c-a66bca095a99", "Q3", "LNE GROUP", 308811, "PARKER HANNIFIN", 2017, "third_quarter", "MED", "Lobbied for issues related to medical research.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2017-10-10T11:32:38.003000-04:00"], [2021288, "96a5de1f-b959-496e-ac2f-9e354c7107a6", "Q3", "SI-BONE, INC.", 401104473, "SI-BONE, INC.", 2017, "third_quarter", "MED", "Reimbursement coverage for certain covered medical device procedures", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 80864, 0, 0, "2017-10-10T12:34:09.797000-04:00"], [2021460, "ce47f029-d4e3-4b6b-9f52-4c1b2c1ef15a", "Q3", "RUSSELL PUBLIC COMMUNICATIONS", 401104398, "ACCELERATE DIAGNOSTICS, INC.", 2017, "third_quarter", "MED", "Advocated for support of antibiotic resistance research and use of appropriate rapid diagnostic  technology", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2017-10-10T14:53:25.370000-04:00"], [2021504, "f7a8e950-3cf5-47f0-b41f-9c120b61aa46", "Q3", "KASOWITZ LLP", 401103221, "SPECTRUM PHARMACEUTICALS", 2017, "third_quarter", "MED", "Regulation of the medical use of nuclear materials and its effect on cancer patient access.", null, null, null, 0, 0, "2017-10-10T15:52:15.867000-04:00"], [2021582, "ab6da4a0-eff2-4357-8080-c75e7a0e2bba", "Q3", "MCDERMOTT+ LLC", 401103287, "COALITION FOR 21ST CENTURY MEDICINE", 2017, "third_quarter", "MED", "Issues concerning regulation of laboratory-developed tests.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", 80000, null, 0, 0, "2017-10-10T16:43:58.350000-04:00"], [2021658, "77834c4d-49fe-4282-af20-ca9b7f0e4d43", "Q3", "WAKE FOREST UNIVERSITY HEALTH SCIENCES", 6781, "WAKE FOREST UNIVERSITY HEALTH SCIENCES", 2017, "third_quarter", "MED", "VA Research funding", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 130000, 0, 0, "2017-10-11T09:04:59.657000-04:00"], [2022077, "d5c2d3d1-e994-40a9-af26-910047b15ca6", "Q3", "PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION", 401103605, "PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION", 2017, "third_quarter", "MED", "Lobbied for timely passage of FDA Reauthorization Act (H.R. 2430, S. 934), for changes to proposed OTC Monograph Safety, Innovation and Reform Act of 2017, and for potential solutions to drug shortage situations, and provided general education about the pharma/biopharma contract services sector.", "HOUSE OF REPRESENTATIVES,SENATE", null, 60000, 0, 0, "2017-10-11T14:21:46.893000-04:00"], [2022375, "f6d0a348-c5a4-44dd-89f9-f0e77954f3fc", "Q3", "NELSON MULLINS RILEY & SCARBOROUGH", 285871, "NATERA, INC.", 2017, "third_quarter", "MED", "Biomedical research, maternal health, and genetic testing", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2017-10-12T09:37:10.360000-04:00"], [2022418, "b5d88fd8-2655-4bf2-89d2-65645c466ca6", "Q3", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "OPERATION SPEC-OPS ADVANCE FOUNDATION", 2017, "third_quarter", "MED", "Educate policymakers, defense committees, defense community, industry and veterans community on the client.  Secure funding for education and placement of special operations service members accepted into client's program", "Defense, Dept of (DOD),Veterans Affairs, Dept of (VA)", 10000, null, 0, 0, "2017-10-12T10:17:06.850000-04:00"], [2022783, "9ea8f844-3e09-47e1-958b-d27bca912f7a", "Q3", "CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER", 312496, "CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER", 2017, "third_quarter", "MED", "NIH funding  HHS budget bill, PREA re-authorization, cancer moonshot", "Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", null, 58708, 0, 0, "2017-10-12T14:12:43.850000-04:00"], [2022810, "2edc5a95-2b9d-46fe-ae30-9d403e699e5a", "Q3", "POYNER SPRUILL LLP", 400563685, "AMERICAN COLLEGE OF SPORTS MEDICINE, INC.", 2017, "third_quarter", "MED", "vital role of physical activity and sports, fitness (including the President's Council on Physical Fitness, Nutrition and Sports), worksite wellness activities, disease prevention through healthy lifestyles, promotion of good health and diet, funding for Labor, HHS and Education Appropriation Bills, concussion legislation, good nutrition and infrastructure initiatives for pedestrians and cyclists and other health-related matters.", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2017-10-12T14:27:02.097000-04:00"], [2022831, "6af0a834-0254-48c1-89f4-33cced960997", "Q3", "INTUITIVE SURGICAL, INC.", 400670004, "INTUITIVE SURGICAL, INC.", 2017, "third_quarter", "MED", "comparative effectiveness research in healthcare", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", null, 40000, 0, 0, "2017-10-12T14:41:20.093000-04:00"], [2023555, "098bd1ab-92a6-4df1-b688-cdb5547cb779", "Q3", "JEFFREY J. KIMBELL & ASSOCIATES, INC.", 46038, "SANTHERA PHARMACEUTICALS (USA), INC.", 2017, "third_quarter", "MED", "Issues related to development of treatments for rare diseases.", "HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2017-10-13T13:23:51.863000-04:00"], [2023576, "d7075696-c2ba-4d3f-969f-a456fd1a84a3", "Q3", "JEFFREY J. KIMBELL & ASSOCIATES, INC.", 46038, "FUJIREBIO DIAGNOSTICS, INC.", 2017, "third_quarter", "MED", "Issues related to medical devices and lab developed tests.", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2017-10-13T13:35:08.297000-04:00"], [2023634, "7a8893d0-342d-449f-85b6-20d7e2a32234", "Q3", "MARSHFIELD CLINIC HEALTH SYSTEM", 57830, "MARSHFIELD CLINIC HEALTH SYSTEM", 2017, "third_quarter", "MED", "Protecting Access to Medicare Act of 2014 (PAMA)\nPAMA includes reforms to the Clinical Lab Fee Schedule (CLFS).  This rule for PAMA requires reporting of Clinical lab prices and volumes.  MCHS requested a delay in the reporting, and changes to expand the definition of applicable lab to represent the true market of all laboratories; requested greater transparency of calculations; more time to allow for gathering data and implementation.", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)", null, 100000, 0, 0, "2017-10-13T14:10:42.740000-04:00"], [2024045, "b353a5cf-75c9-4bcc-b840-aad5733a4627", "Q3", "K&L GATES, LLP", 32098, "VGM GROUP, INC. D/B/A VGM & ASSOCIATES", 2017, "third_quarter", "MED", "BREATH Act, all provisions (not yet introduced).", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2017-10-14T11:46:46.457000-04:00"], [2024120, "9eb95cab-2ee6-42e9-b1fe-e1c204e17452", "Q3", "BROYDRICK & ASSOCIATES", 7268, "EXACT SCIENCES", 2017, "third_quarter", "MED", "Legislation on cancer screening test process.", "Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2017-10-15T13:20:10.460000-04:00"], [2024129, "729b140d-93ca-4c40-8dc3-d1a3b58d3cfd", "Q3", "BROYDRICK & ASSOCIATES", 7268, "NORTHSTAR RADIOISOTOPES, LLC", 2017, "third_quarter", "MED", "DOE policies and cooperative agreements expansion legislation.  Nuclear medicine and CMS Reimbursement. NNSA reorganization, S512 Uranium production (2017). DOE appropriations.", "Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2017-10-15T13:28:19.507000-04:00"], [2024145, "1511b1d4-a398-4663-be92-2719a9f63ea6", "Q3", "FRANCIS EDWARD & CRONIN, INC.", 311314, "CURE ALZHEIMER'S FUND", 2017, "third_quarter", "MED", "Legislation related to Alzheimer's disease research.", "HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 20000, null, 0, 0, "2017-10-15T19:02:39.823000-04:00"], [2024146, "f9c2e380-06ca-4d6a-9a01-1fb9376cf079", "Q3", "FRANCIS EDWARD & CRONIN, INC.", 311314, "PATH DECISION SUPPORT SOFTWARE, LLC", 2017, "third_quarter", "MED", "Issues and legislation related to diabetes diagnosis and treatment.", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", null, null, 0, 0, "2017-10-15T19:04:41.263000-04:00"], [2024208, "5bed74bb-f85a-4a72-93ff-3db7e8d68b22", "Q3", "SRI INTERNATIONAL", 90990, "SRI INTERNATIONAL", 2017, "third_quarter", "MED", "FY18 Labor-HHS-Education Appropriations", "HOUSE OF REPRESENTATIVES,SENATE", null, 8000, 0, 0, "2017-10-16T09:24:42.903000-04:00"], [2024280, "a8cc5f9f-dd19-4ee2-94b6-238eba7c4c0b", "Q3", "THE PETRIZZO GROUP, INC.", 305932, "FRED HUTCHINSON CANCER RESEARCH CENTER", 2017, "third_quarter", "MED", "Advocated for increased funding for NIH and NCI. Advocated for precision medicine and precision oncology issues. Advocated for clinical research administrative reforms. Advocated against any reductions to indirect cost reimbursement rates provided by NIH.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2017-10-16T09:54:32.710000-04:00"], [2024287, "6ee1eb0d-5629-413b-8a17-df3ca686cda2", "Q3", "MCDERMOTT WILL & SCHULTE LLP", 24338, "MAYO CLINIC", 2017, "third_quarter", "MED", "Issues impacting academic medical centers.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2017-10-16T09:55:37.693000-04:00"], [2024288, "20d6b709-4254-4612-b2a0-e8ef7d23965d", "Q3", "THE PETRIZZO GROUP, INC.", 305932, "ALLEN INSTITUTE", 2017, "third_quarter", "MED", "Advocated for funding of the BRAIN Initiative and full funding for NIH. Advocated for the development of open data hosting, and integrated, scalable data analysis hubs for the BRAIN Initiative at NIH.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2017-10-16T09:56:38.773000-04:00"], [2024308, "7924776c-e243-4aaa-85dc-7b91ceefb551", "Q3", "THE PETRIZZO GROUP, INC.", 305932, "OMEROS CORPORATION", 2017, "third_quarter", "MED", "Advocated for Medicare Part B packaged payment reform.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2017-10-16T10:06:50.773000-04:00"], [2024372, "1c0b71d2-9b3a-42db-b7d9-560b15956c2f", "Q3", "PARALYZED VETERANS OF AMERICA", 30724, "PARALYZED VETERANS OF AMERICA", 2017, "third_quarter", "MED", "Department of Veterans Affairs, Medical Research Issues\nNational Institutes of Health, Medical Research Issues", "HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)", null, 82862, 0, 0, "2017-10-16T10:32:25.200000-04:00"], [2024428, "fabd86e4-9813-48db-9dd9-61b98260b3b8", "Q3", "ALEXION PHARMACEUTICALS, INC.", 400504482, "ALEXION PHARMACEUTICALS, INC.", 2017, "third_quarter", "MED", "PDUFA Reauthorization\nRight-to-Try Legislation\nRACE for Children Act", "HOUSE OF REPRESENTATIVES,SENATE", null, 275000, 0, 0, "2017-10-16T10:46:55.497000-04:00"], [2024916, "bd64049a-a917-416d-9b1b-d7e3fd73259a", "Q3", "HANCE SCARBOROUGH", 17443, "TEXAS ALLIANCE FOR PATIENT ACCESS", 2017, "third_quarter", "MED", "Issues related to federal malpractice legislation.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2017-10-16T13:30:21.937000-04:00"], [2024945, "71d3caf7-1db2-4a11-90d9-4858bb81f35f", "3T", "HANCE SCARBOROUGH", 17443, "TEXAS ALLIANCE FOR PATIENT ACCESS", 2017, "third_quarter", "MED", "Issues related to federal malpractice legislation.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 1, "2017-10-16T13:34:38.407000-04:00"], [2024966, "b0fd48cf-d920-4c6a-9eca-1ad0de22facc", "Q3", "THE O TEAM LLC", 400783359, "THE SUZANNE WRIGHT FOUNDATION", 2017, "third_quarter", "MED", "Pancreatic cancer awareness.", "HOUSE OF REPRESENTATIVES,SENATE", 90000, null, 0, 0, "2017-10-16T13:41:51.440000-04:00"], [2025120, "5d553d37-5b93-47f1-8a3e-9a49756b8dda", "Q3", "WILLIAMS AND JENSEN, PLLC", 41454, "GLOBAL DOWN SYNDROME FOUNDATION", 2017, "third_quarter", "MED", "Support for down syndrome research funding.", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2017-10-16T14:11:27.163000-04:00"], [2025160, "1c8f05c9-e3b8-44aa-96cd-cab49cbd0a97", "Q3", "LUCY CALAUTTI", 401104011, "CHILDREN'S HOSPITAL ASSOCIATION", 2017, "third_quarter", "MED", "Repeal and replace Affordable Care Act legislation; Medicaid funding; per capita caps in Medicaid.\nChildren's Health Insurance Program.", null, 30000, null, 0, 0, "2017-10-16T14:16:51.460000-04:00"], [2025316, "2290011e-b827-458d-9cb3-43154aee7061", "Q3", "WINNING STRATEGIES WASHINGTON", 50796, "HEALTHCARE INSTITUTE OF NEW JERSEY", 2017, "third_quarter", "MED", "Monitor Prescription Drug User Fee Act re-authorization", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2017-10-16T14:36:31.363000-04:00"], [2025526, "21ecb2bf-1e22-40d7-ad7a-eb9d0bb4528e", "Q3", "WINNING STRATEGIES WASHINGTON", 50796, "LAHEY HEALTH", 2017, "third_quarter", "MED", "Rural wage index Medicare Reform", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2017-10-16T15:01:28.287000-04:00"], [2025530, "8f6b90cc-de2d-4c17-b0bc-22732573b0f8", "Q3", "WILLIAMS AND JENSEN, PLLC", 41454, "BIOGEN IDEC", 2017, "third_quarter", "MED", "Prescription drug user fee agreements and general education about FDA approval polices and NIH research activities.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2017-10-16T15:02:30.897000-04:00"], [2025540, "b41895eb-89e8-4629-b767-63cb5b9ff315", "Q3", "WILLIAMS AND JENSEN, PLLC", 41454, "SANOFI, U.S.", 2017, "third_quarter", "MED", "General education about FDA approval policies and NIH research activities.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2017-10-16T15:03:36.787000-04:00"], [2025625, "b04d276c-593d-42c5-8629-57516a8e7f19", "Q3", "WILLIAMS AND JENSEN, PLLC", 41454, "VERTEX PHARMACEUTICALS INCORPORATED", 2017, "third_quarter", "MED", "Prescription drug user fee agreements and general education about FDA approval policies and NIH research activities.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2017-10-16T15:20:26.383000-04:00"], [2025641, "41e74fca-ae3f-4037-a97b-d8d821761e27", "Q3", "FORBES-TATE", 400976792, "GENENTECH", 2017, "third_quarter", "MED", "Issues related to Right to Try.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2017-10-16T15:25:33.757000-04:00"], [2025784, "7cd416c6-e379-447b-b4d5-09d1c695829d", "Q3", "FORBES-TATE", 400976792, "PHRMA", 2017, "third_quarter", "MED", "Issues related to \"Right to Try\" legislation.", "HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2017-10-16T16:03:57.480000-04:00"], [2025979, "8b573a16-b7d6-49b4-9a6c-3e670b950143", "Q3", "THE PAUL LAXALT GROUP", 22325, "THE ROGOSIN INSTITUTE", 2017, "third_quarter", "MED", "Monitor issues concerning improvements in medical research and treatment of kidney disease. \nCreating High-Quality Results and Outcomes Necessary to Improve Chronic Care Act of 2017 - S. 870", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2017-10-16T17:04:30.987000-04:00"], [2026274, "0cd56006-ee6e-4012-914e-8ac9157a1da4", "Q3", "CAPITOL HILL STRATEGIES,  LLC", 91774, "BIOTECHNOLOGY INDUSTRY ORGANIZATION", 2017, "third_quarter", "MED", "H.R. 2430, the FDA Reauthorization Act (FDARA) of 2017, legislation to reauthorize the Prescription Drug User Fee Act (PDUFA), as reauthorized by the Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA).", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2017-10-17T09:30:04.430000-04:00"], [2026541, "be1b8fe8-9847-4cf0-99db-7da7ee807b1a", "Q3", "SIDLEY AUSTIN LLP", 35230, "CORD BLOOD ASSOCIATION", 2017, "third_quarter", "MED", "Legislative and Federal agency activities related to H.R.2820 (Health Equity Act of 2013) and the Stem Cell Therapeutic and Research Reauthorization Act of 2015", "Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA)", 10000, null, 0, 0, "2017-10-17T10:43:14.643000-04:00"], [2026729, "8562264c-f7d7-49cc-895b-8648714f5d5d", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "TUBEROUS SCLEROSIS ALLIANCE", 2017, "third_quarter", "MED", "HR 3358/HR 3354/S 1771, FY 2018, Labor-HHS-Education Appropriations bill, Tuberous Sclerosis, research at the National Institutes of Health and the Centers for Disease Control and Prevention.\nHR 3219/ HR 3354, FY 2018 Defense Appropriations Act, Tuberous Sclerosis Medical Research program\nHR 2810/S 1519, National Defense Authorization Act, DoD medical research programs\nHR 1628, Better Care Reconciliation Act\nHR 1628, American Health Care Act", "HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 30000, null, 0, 0, "2017-10-17T11:35:14.007000-04:00"], [2026784, "16f55116-33ab-4e3b-a62f-e07e3385b075", "Q3", "FAEGRE DRINKER BIDDLE & REATH LLP", 12631, "AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE", 2017, "third_quarter", "MED", "Public Health Programs for Infectious and Tropical Disease; NIH Research; Issues related to government agency conference travel; malaria and NDT caucus membership.", "Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,U.S. Agency for International Development (USAID)", 30000, null, 0, 0, "2017-10-17T11:50:36.227000-04:00"], [2026910, "cecc85f0-5bd1-43e5-bed4-fdbc11083918", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "ENDOCRINE SOCIETY", 2017, "third_quarter", "MED", "Research in Endocrinology", "Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 30000, null, 0, 0, "2017-10-17T12:17:59.827000-04:00"], [2026967, "9184bfaa-bad0-41e7-be6e-0ea08e890501", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "HEREDITARY HEMORRHAGIC TELANGIECTASIA FOUNDATION", 2017, "third_quarter", "MED", "Research opportunities at the Department of Defense and the Centers for Disease Control.\nHR 3358/ HR 3354/ S 1771, FY 2018, Labor-HHS Appropriations Act, blood and bleeding disorders.\nHR 3219/HR 3354, FY 18 Defense Appropriations Act, defense medical research\nHR 2810/ S 1519, National Defense Authorization Act, DoD medical research programs\nHR 1628, Better Care Reconciliation Act\nHR 1628, American Health Care Act", "HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 10000, null, 0, 0, "2017-10-17T12:26:31.280000-04:00"], [2026971, "0c76beb4-ceb0-480f-b88b-d4e16082b541", "Q3", "PALMETTO GROUP", 18570, "INTERNATIONAL AIDS VACCINE INITIATIVE", 2017, "third_quarter", "MED", "Federal Funding of AIDS vaccine \nDepartment of State, Foreign Operations, and Related Programs Appropriations Act", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2017-10-17T12:27:33.607000-04:00"], [2027141, "5d82f507-01a0-4532-b299-b1bda6f35820", "Q3", "SQUIRE PATTON BOGGS", 30906, "ALLIANCE FOR BIOSECURITY", 2017, "third_quarter", "MED", "Preparedness and response as it relates to Biosecurity.", "Health & Human Services, Dept of (HHS)", 80000, null, 0, 0, "2017-10-17T13:21:27.193000-04:00"], [2027159, "e1bbb22f-a9f7-40d8-b360-fa3d2fdf504f", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "AMERICAN BRAIN TUMOR ASSOCIATION", 2017, "third_quarter", "MED", "HR 3219/ HR 3354, FY 18 Defense Appropriations Act, defense medical research programs\nHR 3358/HR 3354/S 1771, Labor-HHS, cancer research\nHR 1628, American Health Care Act\nHR 1628, Better Care Reconciliation Act\nHR 2810/ S 1519, National Defense Authorization Act, DoD medical research programs", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 20000, null, 0, 0, "2017-10-17T13:25:40.660000-04:00"], [2027210, "55a5ade0-8186-4f9f-a374-46d05436fd84", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "AMERICAN SOCIETY OF HEMATOLOGY", 2017, "third_quarter", "MED", "Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease; HR 2410 SCD Research, Surveillance Prevention and Treatment Act of 2017", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 30000, null, 0, 0, "2017-10-17T13:35:10.350000-04:00"], [2027226, "2a84c594-b784-4943-8bc2-55f056ffd52f", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "NATIONAL ASSOCIATION OF EPILEPSY CENTERS", 2017, "third_quarter", "MED", "Research and public health programs in epilepsy.", "Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 10000, null, 0, 0, "2017-10-17T13:36:14.210000-04:00"], [2027250, "ba5a919f-80ec-4165-8b60-9ed9add90b7a", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "NATIONAL HEMOPHILIA FOUNDATION", 2017, "third_quarter", "MED", "Hemophilia research, prevention, surveillance and service programs and issues.", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 50000, null, 0, 0, "2017-10-17T13:40:24.837000-04:00"], [2027287, "2f132932-0c8f-48ff-a56c-3ea475d58dd0", "Q3", "HOGAN LOVELLS US LLP", 18422, "COALITION FOR CELL BIOLOGY", 2017, "third_quarter", "MED", "Issues relating to the federal funding of biomedical research.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2017-10-17T13:46:43.147000-04:00"], [2027425, "35694329-756a-4b3b-9f13-13d87e074f6b", "Q3", "FAEGRE DRINKER BIDDLE & REATH LLP", 12631, "DRUGS FOR NEGLECTED DISEASES INITIATIVE OF NORTH AMERICA", 2017, "third_quarter", "MED", "Issues related to priority review voucher for tropical diseases.", "HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", 10000, null, 0, 0, "2017-10-17T14:23:13.060000-04:00"], [2027503, "881a25ba-4f68-4252-9f0b-3eb5990f60d7", "Q3", "SQUIRE PATTON BOGGS", 30906, "MOLNLYCKE HEALTH CARE US, LLC", 2017, "third_quarter", "MED", "Pursuance of approval from relevant agencies of a medical pilot program and gathering support from Congressional leaders.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES", 40000, null, 0, 0, "2017-10-17T14:43:00.983000-04:00"], [2027585, "690283f7-caeb-45a4-9320-ccb68fd8cdd4", "Q3", "STANFORD UNIVERSITY", 36492, "STANFORD UNIVERSITY", 2017, "third_quarter", "MED", "Affordable Care Act Reform\n\nHealth Professions Programs\n\nGraduate Medical Education Funding\n\nPediatric GME Programs\n\nPrecision Medicine Initiative", "Energy, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE", null, 90000, 0, 0, "2017-10-17T14:59:45.923000-04:00"], [2027615, "2ad30626-6027-46a1-9936-2097581d571c", "Q3", "SQUIRE PATTON BOGGS", 30906, "THOMAS JEFFERSON UNIVERSITY", 2017, "third_quarter", "MED", "Advancing health system legislative and regulatory issues including:  programs to reduce health disparities; the development of a collaborative, interdisciplinary translational cancer research program; develop the Partners in Innovation, Education, and Research (PIER) program; and expand access to specialized health care through telehealth.", "SENATE", 60000, null, 0, 0, "2017-10-17T15:07:07.127000-04:00"], [2027660, "6b61df6c-cb73-467b-a1b5-217aedb49c1c", "Q3", "SQUIRE PATTON BOGGS", 30906, "UNIVERSITY OF GEORGIA", 2017, "third_quarter", "MED", "Traumatic brain injury research, funding, and outreach opportunities.", "Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES", 40000, null, 0, 0, "2017-10-17T15:14:34.673000-04:00"], [2028071, "8adfc6ac-7d2e-43c0-8bf2-11f8866cef49", "Q3", "HOGAN LOVELLS US LLP", 18422, "COLDCHAIN TECHNOLOGY SERVICES", 2017, "third_quarter", "MED", "Pursuing opportunities for better logistical application for storage and delivery of vaccines.", "Commerce, Dept of (DOC),Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2017-10-17T16:27:35.853000-04:00"], [2028193, "1dc56a40-e676-4c44-a37d-af05d845712e", "Q3", "MICHAEL N. MCCARTY LAW OFFICE PLLC", 401104300, "AMERICAN MEDICAL TECHNOLOGISTS", 2017, "third_quarter", "MED", "Regulation of Laboratory Developed Tests; Funding for harmonization of diagnostic test results; House and Senate legislation to repeal and replace or amend the Affordable Care Act, particularly as such legislation may affect access to clinical laboratory services.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2017-10-17T17:12:05.797000-04:00"], [2028384, "a2172cfb-f58e-47a1-9784-6dd7521f7550", "3T", "PODESTA GROUP, INC.", 31680, "HUMAN LONGEVITY, INC.", 2017, "third_quarter", "MED", "Healthcare and biotechnology.\nGenetic non-discrimination. \nRegulation of diagnostic tests.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 1, "2017-10-17T18:41:45.720000-04:00"], [2028484, "dfeb5bfd-0a90-4a02-beaa-88afdbfd19bd", "3A", "HOGAN LOVELLS US LLP", 18422, "HEARTFLOW, INC.", 2017, "third_quarter", "MED", "Medicare payment issues", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 90000, null, 0, 0, "2017-10-17T22:44:10.093000-04:00"], [2028637, "0bc31222-af3a-4324-9616-72ff2118b79f", "Q3", "THE CJR GROUP, INC.", 288293, "UNIVERSITY HOSPITALS HEALTH SYSTEM", 2017, "third_quarter", "MED", "Issues impacting hospitals", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2017-10-18T09:25:12.793000-04:00"], [2028816, "ac7d7cea-fd84-4181-957b-ac5ac2fa692f", "Q3", "WILLIAMS AND JENSEN, PLLC", 41454, "MT PHARMA AMERICA, INC.", 2017, "third_quarter", "MED", "Matters affecting access to and pricing of pharmaceuticals; matters affecting the Orphan Drug Act.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2017-10-18T10:10:59.813000-04:00"], [2028938, "629f73e5-feb9-436d-99de-1d9103134c5e", "Q3", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "CHILDREN'S NATIONAL MEDICAL CENTER", 2017, "third_quarter", "MED", "Representation on health-related issues including reimbursement, research, public-health & clinical care", "Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 50000, null, 0, 0, "2017-10-18T10:30:12.283000-04:00"], [2029027, "40c18051-800a-4550-b19e-b3eb728539b3", "Q3", "CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC.", 401103415, "CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC.", 2017, "third_quarter", "MED", "Implementation of the 21st Century Cures Act, provisions related to pediatric training and research. Establishment of a pediatric program office or coordinating council at the National Institutes of Health", "HOUSE OF REPRESENTATIVES,SENATE", null, 130000, 0, 0, "2017-10-18T10:40:06.147000-04:00"], [2029041, "0c68780a-4660-4c45-9427-795c6d2d98d7", "Q3", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "CITY OF HOPE MEDICAL CENTER", 2017, "third_quarter", "MED", "Medicare/Medicaid reimbursement, clinical research", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2017-10-18T10:43:15.410000-04:00"], [2029131, "ddfb4466-9294-4939-8c61-970a91812ca8", "Q3", "PUBLIC SPHERE, INC.", 401104153, "SI-BONE", 2017, "third_quarter", "MED", "General company overview for members and staff.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2017-10-18T10:51:59.897000-04:00"], [2029134, "76004405-efe7-417c-bd9a-ec814215fc03", "Q3", "FAEGRE DRINKER BIDDLE & REATH LLP", 12631, "PREECLAMPSIA FOUNDATION", 2017, "third_quarter", "MED", "Preeclampsia Research Issues.", "HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 10000, null, 0, 0, "2017-10-18T10:52:03.147000-04:00"], [2029155, "d83d8954-c063-4869-baac-0647f9524e77", "Q3", "NATIONAL ENVIRONMENTAL HEALTH ASSOCIATION", 401103538, "NATIONAL ENVIRONMENTAL HEALTH ASSOCIATION", 2017, "third_quarter", "MED", "Increase funding for labs for Zika research", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2017-10-18T10:55:14.087000-04:00"], [2029213, "724a2b7e-3325-4276-b4cb-2f4929e82cf1", "Q3", "HOGAN LOVELLS US LLP", 18422, "SPECIALISTS ON CALL", 2017, "third_quarter", "MED", "Identifying telemedicine opportunities in the federal contracting areas.", "HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)", 20000, null, 0, 0, "2017-10-18T11:11:53.663000-04:00"], [2029548, "26455ce7-e571-4b96-b536-4b71b0b6e4aa", "Q3", "BRACEWELL LLP", 6837, "AIR LIQUIDE USA LLC", 2017, "third_quarter", "MED", "Work related to medical gases", "Bureau of Land Management (BLM),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Interior, Dept of (DOI),Internal Revenue Service (IRS),SENATE,Treasury, Dept of", 60000, null, 0, 0, "2017-10-18T12:10:34.857000-04:00"], [2029649, "349b9609-956a-4b75-91d7-3c73b285e762", "3T", "EFB ADVOCACY, LLC", 401104430, "QGA PUBLIC AFFAIRS ON BEHALF OF UNITED FOR MEDICAL RESEARCH", 2017, "third_quarter", "MED", "Funding issues related to the National Institutes of Health", "HOUSE OF REPRESENTATIVES,SENATE", 31500, null, 0, 1, "2017-10-18T12:32:24.093000-04:00"], [2029717, "91609100-a51d-4291-af2f-bb96763730d8", "Q3", "OREGON HEALTH & SCIENCE UNIVERSITY", 30291, "OREGON HEALTH & SCIENCE UNIVERSITY", 2017, "third_quarter", "MED", "Impact of Budget Control Act of 2011's Sequestration on medical research; use of animals in biomedical research; moving medical research from bench to bedside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tied with additional review in post-market: \"21st Century Cures Act\" (H.R. 34); FDA regulation of mitochondrial replacement therapy Sections 736 in \"Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017\" (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research program; FDA regulation of laboratory developed test.", "HOUSE OF REPRESENTATIVES,SENATE", null, 70000, 0, 0, "2017-10-18T12:58:05.970000-04:00"], [2029732, "3c0bebff-d6dc-49f8-bd06-b8a4284fb93b", "Q3", "CAPITOL HILL STRATEGIES,  LLC", 91774, "BIOGEN INC", 2017, "third_quarter", "MED", "Issues dealing with newborn screening.\nH.R. 2430, the FDA Reauthorization Act (FDARA) of 2017, legislation to reauthorize the Prescription Drug User Fee Act (PDUFA), as reauthorized by the Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA).\nIssues dealing with Alzheimer's treatments", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2017-10-18T13:01:48.367000-04:00"], [2029947, "b7cc8526-1670-4542-a62a-82f82b725c8f", "Q3", "MWW GROUP", 26318, "NORTHEAST OHIO UNIVERSITIES COLLEGES OF MEDICINE AND PHARMACY (NEOMED)", 2017, "third_quarter", "MED", "Research and funding opportunities in general and for newly discovered mechanisms and tests for human testing, including for listeria and Zika;\nSTEM-M school and STEM education opportunities", "Defense, Dept of (DOD),Education, Dept of,Justice, Dept of (DOJ),Natl Institutes of Health (NIH)", 10000, null, 0, 0, "2017-10-18T14:04:12.087000-04:00"], [2029960, "071e63f6-f797-46f9-af18-669d341951e0", "Q3", "SPINA BIFIDA ASSOCIATION OF AMERICA", 46665, "SPINA BIFIDA ASSOCIATION OF AMERICA", 2017, "third_quarter", "MED", "Activities to support the Spina Bifida community and research relating to all people affected by Spina Bifida", "Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", null, 12821, 0, 0, "2017-10-18T14:04:14.510000-04:00"], [2030003, "faf207cf-9ee2-4dee-946a-8d6067f38d29", "Q3", "MWW GROUP", 26318, "THOMAS JEFFERSON UNIVERSITY AND HEALTH SYSTEM", 2017, "third_quarter", "MED", "NCI designated cancer centers program;\nComputational Biology;\nFunding for NIH Specialized Programs of Research Excellence (SPORE) grants;\nHealth disparities research;\nRegional Clinical Trial networks;\nTelestroke/telehealth/telemedicine programs;\nGlobal programs;\nCampus visits on research", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Natl Science Foundation (NSF),SENATE,State, Dept of (DOS)", 40000, null, 0, 0, "2017-10-18T14:08:34.480000-04:00"], [2030108, "2b6fdb03-1777-4fbe-8452-2352a261dbe8", "Q3", "LOCKRIDGE, GRINDAL, NAUEN, PLLP", 23053, "HENNEPIN COUNTY MEDICAL CENTER", 2017, "third_quarter", "MED", "FY2018 Authorizations, Appropriations, and Budget Policy", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2017-10-18T14:26:30.577000-04:00"], [2030261, "639e53cc-1137-4d4f-bbed-beb315cb86d9", "Q3", "THE CORMAC GROUP, LLC", 66773, "KESSLER FOUNDATION", 2017, "third_quarter", "MED", "Appropriations, DOD, TBI Research, Veterans Issues", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2017-10-18T14:50:06.453000-04:00"], [2030462, "1818a38a-0a42-4b20-bcca-725f754cfd43", "Q3", "CATHOLIC HEALTH ASSOCIATION OF THE UNITED STATES", 8497, "CATHOLIC HEALTH ASSOCIATION OF THE UNITED STATES", 2017, "third_quarter", "MED", "Supported the creation of additional ICD-10-CM medical diagnosis codes to account for human trafficking victims in clinical settings.", "Centers For Disease Control & Prevention (CDC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 190000, 0, 0, "2017-10-18T15:09:08.517000-04:00"], [2030475, "d5e9d15f-5867-4ee2-8179-d56de6019c5d", "Q3", "INDIANA CHAMBER OF COMMERCE, INC.", 19263, "INDIANA CHAMBER OF COMMERCE INC", 2017, "third_quarter", "MED", "Health Care Reform", "Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE", null, 40000, 0, 0, "2017-10-18T15:16:18.627000-04:00"], [2030559, "daf9548d-178f-44fc-b407-672df209086d", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "ASSOCIATION FOR MOLECULAR PATHOLOGY", 2017, "third_quarter", "MED", "Regulation of laboratory diagnostics\nNo bill number, Diagnostic Accuracy and Innovation Act", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2017-10-18T15:31:21.520000-04:00"]], "truncated": false, "filtered_table_rows_count": 271, "expanded_columns": [], "expandable_columns": [[{"column": "filing_uuid", "other_table": "lobbying_filings_raw", "other_column": "filing_uuid"}, "registrant_name"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, filing_uuid, filing_type, registrant_name, registrant_id, client_name, filing_year, filing_period, issue_code, specific_issues, government_entities, income_amount, expense_amount, is_no_activity, is_termination, received_date from lobbying_activities where \"filing_period\" = :p0 and \"filing_year\" = :p1 and \"issue_code\" = :p2 order by filing_year desc limit 101", "params": {"p0": "third_quarter", "p1": "2017", "p2": "MED"}}, "facet_results": {"issue_code": {"name": "issue_code", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2017&issue_code=MED", "results": [{"value": "MED", "label": "MED", "count": 271, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2017", "selected": true}], "truncated": false}, "filing_year": {"name": "filing_year", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2017&issue_code=MED", "results": [{"value": 2017, "label": 2017, "count": 271, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&issue_code=MED", "selected": true}], "truncated": false}, "filing_period": {"name": "filing_period", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2017&issue_code=MED", "results": [{"value": "third_quarter", "label": "third_quarter", "count": 271, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_year=2017&issue_code=MED", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "filing_type", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2017&issue_code=MED&_facet=filing_type"}, {"name": "income_amount", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2017&issue_code=MED&_facet=income_amount"}, {"name": "is_termination", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2017&issue_code=MED&_facet=is_termination"}, {"name": "received_date", "type": "date", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2017&issue_code=MED&_facet_date=received_date"}], "next": "2017,2030559", "next_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2017&issue_code=MED&_next=2017%2C2030559&_sort_desc=filing_year", "private": false, "allow_execute_sql": true, "query_ms": 2092.8137849550694, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}